1. Home
  2. PCRX vs LZM Comparison

PCRX vs LZM Comparison

Compare PCRX & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • LZM
  • Stock Information
  • Founded
  • PCRX 2006
  • LZM 2021
  • Country
  • PCRX United States
  • LZM Isle of Man
  • Employees
  • PCRX N/A
  • LZM N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • LZM Metal Mining
  • Sector
  • PCRX Health Care
  • LZM Basic Materials
  • Exchange
  • PCRX Nasdaq
  • LZM Nasdaq
  • Market Cap
  • PCRX 604.7M
  • LZM 563.7M
  • IPO Year
  • PCRX 2011
  • LZM N/A
  • Fundamental
  • Price
  • PCRX $18.98
  • LZM $6.55
  • Analyst Decision
  • PCRX Buy
  • LZM Strong Buy
  • Analyst Count
  • PCRX 10
  • LZM 2
  • Target Price
  • PCRX $26.60
  • LZM $12.50
  • AVG Volume (30 Days)
  • PCRX 933.0K
  • LZM 110.6K
  • Earning Date
  • PCRX 11-06-2024
  • LZM 12-31-2024
  • Dividend Yield
  • PCRX N/A
  • LZM N/A
  • EPS Growth
  • PCRX N/A
  • LZM N/A
  • EPS
  • PCRX N/A
  • LZM N/A
  • Revenue
  • PCRX $694,957,000.00
  • LZM $1,020,728.00
  • Revenue This Year
  • PCRX $4.94
  • LZM N/A
  • Revenue Next Year
  • PCRX N/A
  • LZM $890.00
  • P/E Ratio
  • PCRX N/A
  • LZM N/A
  • Revenue Growth
  • PCRX 4.40
  • LZM N/A
  • 52 Week Low
  • PCRX $11.16
  • LZM $4.52
  • 52 Week High
  • PCRX $35.95
  • LZM $9.97
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 54.07
  • LZM 43.18
  • Support Level
  • PCRX $18.73
  • LZM $6.50
  • Resistance Level
  • PCRX $20.34
  • LZM $7.13
  • Average True Range (ATR)
  • PCRX 1.13
  • LZM 0.32
  • MACD
  • PCRX -0.03
  • LZM -0.04
  • Stochastic Oscillator
  • PCRX 64.09
  • LZM 18.68

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises two segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary.

Share on Social Networks: